U.S. Markets open in 2 hrs 50 mins
  • S&P Futures

    +5.75 (+0.16%)
  • Dow Futures

    +51.00 (+0.17%)
  • Nasdaq Futures

    +40.50 (+0.33%)
  • Russell 2000 Futures

    -2.80 (-0.15%)
  • Crude Oil

    -0.40 (-0.88%)
  • Gold

    +0.80 (+0.04%)
  • Silver

    -0.14 (-0.58%)

    +0.0013 (+0.1073%)
  • 10-Yr Bond

    -0.0040 (-0.45%)
  • Vix

    -0.19 (-0.88%)

    +0.0002 (+0.0187%)

    -0.2200 (-0.2110%)

    -380.34 (-2.22%)
  • CMC Crypto 200

    -41.96 (-11.32%)
  • FTSE 100

    -46.63 (-0.73%)
  • Nikkei 225

    +107.40 (+0.40%)

Global Nuclear Medicine Market (2020 to 2025) - by Therapy, Type, Application, Therapeutics, Route of Administration, End-user and Region - ResearchAndMarkets.com

·3 min read

The "Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET, Alpha-emitters, Beta-emitters, Brachytherapy), By Application, By Therapeutics, By Route of Administration, By End-User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Nuclear Medicine Market is estimated to grow at an impressive rate during the forecast period owing to increasing incidence and prevalence of diseases like cancer, initiatives to reduce the demand and supply gap of Mo-99 and increasing research and development activities in radiotherapy to treat various diseases.

Furthermore, nuclear medicines are extensively being used in molecular imaging, which is a technique involving molecules as biomarkers for specific molecular processes that determines the onset or progress of a disease.

Nuclear medicines are convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Due to this major factor, chemotherapy methods are being replaced by radiopharmaceuticals or nuclear medicines for cancer treatment. They are also used in applications such as lymphoma and bone metastasis. Some of the nuclear medicines used in diagnostic procedures are F-18, Tc-99, Ga-67, and I-123 while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedures. These factors are anticipated to drive the Global Nuclear Medicine Market until 2025.

Apart from above mentioned growth factors, the Global Nuclear Medicine Market also faces some restrains. Short half-life of nuclear medicines or radiopharmaceuticals reduces their potential adoption. Other restraining factors include supply shortages, logistical difficulties, and limited number of trained medical personnel.

Companies Mentioned

  • Cardinal Health

  • Curium

  • Lantheus

  • Bracco

  • Advanced Accelerator Applications

  • NTP Radioisotopes

  • Eckert & Ziegler

  • Jubilant DraxImage

  • GE Healthcare

  • Siemens Healthineers

  • Rotem Industries

  • Eczacibasi-Monrol

  • IBA Group

  • Ire-Elit

  • Lucerno Dynamics

  • Positron Corporation

  • NorthStar Medical Radioisotopes

  • Pharmalucence

  • Norgine

  • Roche

Objective of the Study:

  • To analyze and forecast the market size of the Global Nuclear Medicine Market.

  • To classify and forecast the Global Nuclear Medicine Market based on therapy, type, application, therapeutics, route of administration, end-user, company and regional distribution.

  • To identify drivers and challenges for the Global Nuclear Medicine Market.

  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Nuclear Medicine Market.

  • To conduct pricing analysis for the Global Nuclear Medicine Market.

  • To identify and analyze the profile of leading players operating in the Global Nuclear Medicine Market.

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Nuclear Medicine Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value & Volume

5.2. Market Share & Forecast

5.2.1. By Therapy (Radioactive Iodine, Radioactive Antibodies, Radioactive Phosphorus, Others

5.2.2. By Type (SPECT (Single photo emission computed tomography), PET (Positron emission tomography), Alpha-emitters, Beta-emitters, Brachytherapy)

5.2.3. By Application (Cardiology, Respiratory, Orthopaedics, Neurology, Oncology, Urology)

5.2.4. By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Auger Electron Emitters)

5.2.5. By Route of Administration (Oral, Intravenous, Nasal)

5.2.6. By End-User (Hospitals, Diagnostic centers, Others)

5.2.7. By Company (2019)

5.2.8. By Region

5.3. Market Attractiveness Index

6. Asia-Pacific Nuclear Medicine Market Outlook

7. Europe Nuclear Medicine Market Outlook

8. North America Nuclear Medicine Market Outlook

9. South America Nuclear Medicine Market Outlook

10. Middle East and Africa Nuclear Medicine Market Outlook

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1. Competition Outlook

13.2. Players Profiled (Leading Companies)

14. Strategic Recommendations

15. About Us & Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/9a3k15

View source version on businesswire.com: https://www.businesswire.com/news/home/20201118005534/en/


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900